Literature DB >> 7789476

Prospective study of risk factors for early and persistent wheezing in childhood.

S Lewis1, D Richards, J Bynner, N Butler, J Britton.   

Abstract

The object of this study was to determine the relative importance of low birth weight, preterm birth, low maternal age, household size, exposure to maternal smoking, personal smoking at 16 yrs of age, early termination of breastfeeding and socioeconomic status in the aetiology of wheezing illness in the first 5 yrs of life, and on the persistence of this illness at 16 yrs of age. In 15,712 children born in Britain during one week of April 1970, the occurrence of wheezing by 5 yrs of age, and of wheezing in the past year at 16 yrs of age within this group were analysed in multivariate logistic regression against each potential risk factor. The independent determinants of wheezing by 5 yrs of age were male sex, maternal smoking during pregnancy (odds ratio (OR) for 15+ cigarettes.day-1 = 1.39; 95% confidence interval (95% CI) 1.22-1.58) and low birthweight (OR for birthweight < 2.5 kg = 1.26; 95% Cl 1.07-1.50). Of children who had wheezed by 5 yrs of age, 15% reported wheezing in the past 12 months at 16 yrs of age. The persistence of symptoms at 16 yrs of age was independently related to low maternal age (OR for 20 vs 40 yrs of age = 1.96; 95% CI 1.08-3.45) and to high social status (OR for most vs least advantaged = 1.95; 95% CI 1.13-3.38). We conclude that low birth weight and maternal smoking in pregnancy are independent risk factors for early childhood wheezing, but in 85% of children with early wheezing it resolves by 16 yrs of age.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789476     DOI: 10.1183/09031936.95.08030349

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  39 in total

1.  Perinatal risk factors for asthma in Finnish adolescent twins.

Authors:  M Räsänen; J Kaprio; T Laitinen; T Winter; M Koskenvuo; L A Laitinen
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Asthma in preschool children: prevalence and risk factors.

Authors:  M M Haby; J K Peat; G B Marks; A J Woolcock; S R Leeder
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

3.  Relationship between socioeconomic status and asthma: a longitudinal cohort study.

Authors:  R J Hancox; B J Milne; D R Taylor; J M Greene; J O Cowan; E M Flannery; G P Herbison; C R McLachlan; R Poulton; M R Sears
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

Review 4.  Relevance of birth cohorts to assessment of asthma persistence.

Authors:  Robert J Hancox; Padmaja Subbarao; Malcolm R Sears
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

Review 5.  Impact of tobacco smoke on chronic rhinosinusitis: a review of the literature.

Authors:  Douglas D Reh; Thomas S Higgins; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2012-06-13       Impact factor: 3.858

6.  Fetal and postnatal exposure to tobacco smoke and respiratory health in children.

Authors:  Renata Zlotkowska; Jan E Zejda
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 7.  Asthma: epidemiology, etiology and risk factors.

Authors:  Padmaja Subbarao; Piush J Mandhane; Malcolm R Sears
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

8.  Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies.

Authors:  D P Strachan; D G Cook
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

9.  Asthma and airway hyperresponsiveness among Belgian conscripts, 1978-91.

Authors:  P Dubois; E Degrave; O Vandenplas
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

10.  Population-based study on association between birth weight and risk of asthma: a propensity score approach.

Authors:  Hyeon J Yang; Rui Qin; Slavica Katusic; Young J Juhn
Journal:  Ann Allergy Asthma Immunol       Date:  2012-11-10       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.